Home News Insights Trading halts Paper trading Guide Community My account

Market calendarNext market opening

Display in USD

Loading news article.

U.S. stock guide
Scanner guide
Paper trading guide
Terms of service
Privacy policy
Announcements
FAQ

Support: help@wapeb.comPartnerships: partnership@wapeb.com

WAPE is a free research, analysis and paper trading service. It does not place real securities orders. Market data and AI summaries are for information only, not investment advice or stock recommendations. Information may include delays, errors or estimates. Check original sources and supporting materials. You are responsible for your investment decisions and any resulting gains or losses.

Language한국어 English

Copyright © WAPE. All rights reserved.

Loading news article.

CNS Pharmaceuticals Increases Authorized Shares for Equity Plan | WAPE

FilingSEC EDGAR8-K

CNS Pharmaceuticals Increases Authorized Shares for Equity Plan

Oct 2, 2026, 08:00 ET · SEC accepted

StageEquity Plan Approval

Filing content

Shareholders approved an amendment to the 2020 Equity Plan, increasing the number of shares authorized for issuance by 650,000.

AI summary of the filing. Please also check the source.

Related companies

CNS Pharmaceuticals, Inc.CNSPView stock

Analyzed by WAPE AI.

Preparing English content…

Comments —

Comment

Loading comments…